Health

Pharmaxis Reports Phase II Results for Aridol in COPD

SYDNEY, Australia, March 14 /Xinhua-PRNewswire-FirstCall/ -- Pharmaceutical company Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced the results from its Phase II trial for Aridol in subjects with Chronic Obstructive Pulmonary Disease (COPD), a respiratory disease affecting over 30 million p...

2007-03-14 21:00 661

Mindray Medical International Announces Fourth Quarter and Full Year 2006 Results

Rapid International Expansion Drives Record Revenues Company Ends Year with Strong Debt-free Balance Sheet; Declares Cash Dividend of US$0.15 Per Share SHENZHEN, China, March 12 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR) today announced its selecte...

2007-03-12 20:13 752

Protection From Osteoporosis - Bone is Living Tissue

Protection From Osteoporosis - Bone is Living Tissue BASEL, Switzerland, March. 8 /Xinhua-PRNewswire/ -- In Europe, a bone breaks every 30 seconds due to osteoporosis. Each year, nearly 1.5 million Americans over 50 suffer fractures caused by this bone disease. Bone is a living tis...

2007-03-08 12:17 846

China Biopharmaceuticals Holdings' Subsidiary Enshi Pharmaceuticals Wins Two Industry Awards

Our Hepatitis drug, Ganbifu, Named as One of China's 2006 "Top Ten Most Popular Hepatic Drugs" Enshi's General Manager, Peixiang Cong, Honored as One of China's 2006 "Outstanding Managers for Brand Promotion" BEIJING, March 7 /Xinhua-PRNewswire-FirstCall/ -- China Biopharmaceuticals Holdin...

2007-03-07 22:00 679

China Sky One Medical Announces Three New Diagnostic Kits Have Passed National Final Inspection

HARBIN, China, March 6 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. (OTC Bulletin Board: CSKI), one of the leading producers and distributors for external-Chinese medicine in China, has announced that the AMI Diagnostic Kit, Human Urinary Albumin Elisa Kit and Early Pregnancy...

2007-03-06 21:00 778

Sinovac Provides Update on Study of Third Dose of Its Pandemic Influenza Vaccine

BEIJING, March 6 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of biopharmaceutical products in China, today announced an update for the study evaluating the third dose of its vaccine against the H5N1 dose of pandemic influenza. In order to test the immune...

2007-03-06 21:00 1072

Natural Health Trends Corp. Stockholders Filed a Schedule 13-D/A

DALLAS, Texas, March 2 /Xinhua-PRNewswire-FirstCall/ -- Mr. Rudy Ru and a group of stockholders of Natural Health Trends Corp (the "company"; Nasdaq: BHIP), an international direct selling company, announced today that they filed an amended schedule 13-D/A on February 27, 2007. The Ite...

2007-03-02 16:42 1008

Phase II Cystic Fibrosis Study Closes Enrollment

SYDNEY, Australia, March 1 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis Ltd (ASX: PXS; Nasdaq: PXSL) announced on Feb 23 that a Phase II clinical trial of Bronchitol in children with cystic fibrosis has closed its enrollment phase. The study is an independent investigator-initiated study be...

2007-03-01 21:35 732

Mindray to Present at Lehman Brothers 10th Annual Global Healthcare Conference

SHENZHEN, March 1 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today announced that Mr. Xu Hang, Mindray's Chairman and Co-Chief Exe...

2007-03-01 21:00 636

Fourth Phase III Study of Vandetanib (ZACTIMA(TM), ZD6474) in Patients With Advanced Lung Cancer

A Phase III international, parallel group, randomised, double-blind study of vandetanib in combination with pemetrexed for advanced non-small cell lung cancer (NSCLC) after failure of first line anti-cancer therapy -- For Non-US Healthcare Professional Press Only -- ALDERLEY PARK, Ches...

2007-02-26 22:00 900

ScinoPharm's 2006 Revenue and Net Income at Record High

TAINAN, Taiwan, Feb. 26 /Xinhua-PRNewswire/ -- Active pharmaceutical ingredient (API) specialist ScinoPharm reported a 43% rise in its annual revenue to US$44.9 million for 2006, and a positive net income for the first year since the company's inception. Sales on selected anti-oncologics such...

2007-02-26 21:00 744

Elsevier Announces Its Point-Of-Care Medical Information to Be Offered as Part of Chinese Electronic Health Record

Partnership with ChinaMedCom is a First of its Kind Between a U.S. Publisher and a Chinese Healthcare Information Technology Company and Puts FirstCONSULT Evidence-based Clinical Information Directly into Electronic Health Records for Hospitals in China NEW ORLEANS, Feb. 26 /Xinhua-PRNews...

2007-02-26 21:00 901

Lilly Plans New Clinical Trial of Xigris(R)

Trial will help better identify appropriate patient, define the benefit-risk profile in this population INDIANAPOLIS, Feb. 26 /Xinhua-PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced plans for a new clinical study of Xigris(R) (drotrecogin alfa [activated]). The trial is des...

2007-02-26 19:00 759

Sinovac Attended 3rd WHO Meeting on Evaluation of Pandemic Influenza Prototype Vaccines in Clinical Trials

BEIJING, Feb. 20 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of biopharmaceutical products in China, today announced that Sinovac attended the 3rd WHO meeting on evaluation of pandemic influenza prototype vaccines in clinical trials. The meeting was held on Feb...

2007-02-20 21:00 936

Medical Group Inc. to Present at the Roth Capital Partners 19th Annual OC Conference

Presentation Scheduled for Wednesday, February 21 at 1:30 p.m. PT SHENZHEN, China, Feb. 20 /Xinhua-PRNewswire/ -- Winner Medical Group Inc. (OTC Bulletin Board: WMDG), will present at the Roth Capital Partners 19th Annual OC Conference at 1:30 p.m. Pacific Time on Wednesday, February 21 at Th...

2007-02-20 21:30 847

Mindray to Exhibit Latest Ultrasound System at 2007 European Congress of Radiology

SHENZHEN, China, Feb. 16 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today announced that the company will exhibit its newly releas...

2007-02-16 21:00 680

Mindray to Report Fourth Quarter and Fiscal Year 2006 Financial Results on March 12, 2007

Shenzhen, China, Feb. 16 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China, today announced that it will report its financial results for the fourth quarter and fiscal year ended Decembe...

2007-02-16 21:00 682

Mindray Medical Receives Frost & Sullivan 2006 Global Market Penetration Leadership Award in the Patient Monitoring Market

SHENZHEN, China, Feb. 16 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today announced that global growth consulting company, Frost &...

2007-02-16 21:00 987

TaiGen Appoints Dr. Luke Lin VP of Clinical Research & Development

TAIPEI, Taiwan, Feb. 14 /Xinhua-PRNewswire-FirstCall/ -- TaiGen Biotechnology Inc., a private Taiwan based biopharmaceutical company developing novel therapeutics to treat infectious diseases, cancer and diabetic complications, today announced the appointment of Dr. Luke Lin as Vice President...

2007-02-14 22:00 887

Winner Medical Group Reports First Quarter Fiscal 2007 Results

SHENZHEN, China, Feb. 14 /Xinhua-PRNewswire/ -- Winner Medical Group Inc. (OTC Bulletin Board: WMDG), today reported financial results for the first quarter of fiscal year 2007, ending December 31, 2006. Consolidated sales for the first fiscal quarter were $15.9 million compared to $16....

2007-02-14 21:30 940
1 ... 771772773774775776777 ... 779